Intellia Therapeutics Inc (NASDAQ: NTLA): To Buy Or Not To Buy, That Is The Question
Intellia Therapeutics Inc (NTLA) concluded trading on Thursday at a closing price of $32.12, with 4.11 million shares of worth about $132.0 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.89% during that period and on Thursday the price saw a loss of […]